nodes	percent_of_prediction	percent_of_DWPC	metapath
Timolol—ABCB1—hematologic cancer	0.15	1	CbGaD
Timolol—ABCB1—Lenalidomide—hematologic cancer	0.032	0.0644	CbGbCtD
Timolol—CYP2D6—Lomustine—hematologic cancer	0.028	0.0564	CbGbCtD
Timolol—CYP2D6—Idarubicin—hematologic cancer	0.025	0.0503	CbGbCtD
Timolol—CYP2C19—Bortezomib—hematologic cancer	0.0243	0.0489	CbGbCtD
Timolol—CYP2D6—Hydroxyurea—hematologic cancer	0.0212	0.0428	CbGbCtD
Timolol—CYP2C19—Thalidomide—hematologic cancer	0.0212	0.0426	CbGbCtD
Timolol—CYP2C19—Teniposide—hematologic cancer	0.0202	0.0407	CbGbCtD
Timolol—ABCB1—Daunorubicin—hematologic cancer	0.0188	0.0378	CbGbCtD
Timolol—CYP2C19—Ifosfamide—hematologic cancer	0.0186	0.0375	CbGbCtD
Timolol—CYP2D6—Bortezomib—hematologic cancer	0.0185	0.0372	CbGbCtD
Timolol—ABCB1—Alitretinoin—hematologic cancer	0.0184	0.037	CbGbCtD
Timolol—CYP2C19—Imatinib—hematologic cancer	0.0178	0.0359	CbGbCtD
Timolol—ABCB1—Imatinib—hematologic cancer	0.0144	0.0289	CbGbCtD
Timolol—CYP2D6—Imatinib—hematologic cancer	0.0135	0.0273	CbGbCtD
Timolol—ABCB1—Nilotinib—hematologic cancer	0.0131	0.0263	CbGbCtD
Timolol—ABCB1—Vinorelbine—hematologic cancer	0.0129	0.0261	CbGbCtD
Timolol—CYP2D6—Nilotinib—hematologic cancer	0.0123	0.0248	CbGbCtD
Timolol—CYP2D6—Vinorelbine—hematologic cancer	0.0122	0.0246	CbGbCtD
Timolol—CYP2C19—Prednisone—hematologic cancer	0.0117	0.0236	CbGbCtD
Timolol—ABCB1—Dasatinib—hematologic cancer	0.0115	0.0232	CbGbCtD
Timolol—ABCB1—Mitoxantrone—hematologic cancer	0.0114	0.0229	CbGbCtD
Timolol—ABCB1—Betamethasone—hematologic cancer	0.0102	0.0205	CbGbCtD
Timolol—ABCB1—Gemcitabine—hematologic cancer	0.0101	0.0203	CbGbCtD
Timolol—ABCB1—Prednisolone—hematologic cancer	0.01	0.0202	CbGbCtD
Timolol—ABCB1—Prednisone—hematologic cancer	0.00946	0.0191	CbGbCtD
Timolol—ABCB1—Irinotecan—hematologic cancer	0.00897	0.0181	CbGbCtD
Timolol—ABCB1—Vinblastine—hematologic cancer	0.00798	0.0161	CbGbCtD
Timolol—ABCB1—Vincristine—hematologic cancer	0.00784	0.0158	CbGbCtD
Timolol—CYP2D6—Vinblastine—hematologic cancer	0.00752	0.0151	CbGbCtD
Timolol—CYP2C19—Dexamethasone—hematologic cancer	0.00732	0.0147	CbGbCtD
Timolol—ABCB1—Cisplatin—hematologic cancer	0.00731	0.0147	CbGbCtD
Timolol—ABCB1—Etoposide—hematologic cancer	0.00719	0.0145	CbGbCtD
Timolol—ABCB1—Dexamethasone—hematologic cancer	0.00591	0.0119	CbGbCtD
Timolol—CYP2D6—Dexamethasone—hematologic cancer	0.00557	0.0112	CbGbCtD
Timolol—ABCB1—Doxorubicin—hematologic cancer	0.0049	0.00987	CbGbCtD
Timolol—ABCB1—Methotrexate—hematologic cancer	0.00475	0.00956	CbGbCtD
Timolol—CYP2D6—Doxorubicin—hematologic cancer	0.00462	0.0093	CbGbCtD
Timolol—Mediastinal disorder—Epirubicin—hematologic cancer	2.85e-05	9.75e-05	CcSEcCtD
Timolol—Gastrointestinal disorder—Dexamethasone—hematologic cancer	2.85e-05	9.75e-05	CcSEcCtD
Timolol—Gastrointestinal disorder—Betamethasone—hematologic cancer	2.85e-05	9.75e-05	CcSEcCtD
Timolol—Fatigue—Dexamethasone—hematologic cancer	2.84e-05	9.73e-05	CcSEcCtD
Timolol—Fatigue—Betamethasone—hematologic cancer	2.84e-05	9.73e-05	CcSEcCtD
Timolol—Pruritus—Etoposide—hematologic cancer	2.83e-05	9.7e-05	CcSEcCtD
Timolol—Shock—Prednisone—hematologic cancer	2.83e-05	9.67e-05	CcSEcCtD
Timolol—Arrhythmia—Epirubicin—hematologic cancer	2.82e-05	9.67e-05	CcSEcCtD
Timolol—Pain—Dexamethasone—hematologic cancer	2.82e-05	9.65e-05	CcSEcCtD
Timolol—Pain—Betamethasone—hematologic cancer	2.82e-05	9.65e-05	CcSEcCtD
Timolol—Visual impairment—Doxorubicin—hematologic cancer	2.82e-05	9.65e-05	CcSEcCtD
Timolol—Nervous system disorder—Prednisone—hematologic cancer	2.82e-05	9.64e-05	CcSEcCtD
Timolol—Alopecia—Epirubicin—hematologic cancer	2.79e-05	9.56e-05	CcSEcCtD
Timolol—Skin disorder—Prednisone—hematologic cancer	2.79e-05	9.55e-05	CcSEcCtD
Timolol—Nausea—Gemcitabine—hematologic cancer	2.79e-05	9.54e-05	CcSEcCtD
Timolol—Vomiting—Cisplatin—hematologic cancer	2.78e-05	9.52e-05	CcSEcCtD
Timolol—Hyperhidrosis—Prednisone—hematologic cancer	2.78e-05	9.5e-05	CcSEcCtD
Timolol—Vision blurred—Methotrexate—hematologic cancer	2.77e-05	9.49e-05	CcSEcCtD
Timolol—Mental disorder—Epirubicin—hematologic cancer	2.77e-05	9.48e-05	CcSEcCtD
Timolol—Rash—Cisplatin—hematologic cancer	2.76e-05	9.44e-05	CcSEcCtD
Timolol—Dermatitis—Cisplatin—hematologic cancer	2.75e-05	9.43e-05	CcSEcCtD
Timolol—Erythema—Epirubicin—hematologic cancer	2.75e-05	9.42e-05	CcSEcCtD
Timolol—Malnutrition—Epirubicin—hematologic cancer	2.75e-05	9.42e-05	CcSEcCtD
Timolol—Diarrhoea—Etoposide—hematologic cancer	2.74e-05	9.38e-05	CcSEcCtD
Timolol—Anorexia—Prednisone—hematologic cancer	2.74e-05	9.37e-05	CcSEcCtD
Timolol—Eye disorder—Doxorubicin—hematologic cancer	2.73e-05	9.36e-05	CcSEcCtD
Timolol—Tinnitus—Doxorubicin—hematologic cancer	2.73e-05	9.34e-05	CcSEcCtD
Timolol—Feeling abnormal—Betamethasone—hematologic cancer	2.72e-05	9.3e-05	CcSEcCtD
Timolol—Feeling abnormal—Dexamethasone—hematologic cancer	2.72e-05	9.3e-05	CcSEcCtD
Timolol—Cardiac disorder—Doxorubicin—hematologic cancer	2.71e-05	9.29e-05	CcSEcCtD
Timolol—Tension—Epirubicin—hematologic cancer	2.7e-05	9.24e-05	CcSEcCtD
Timolol—Gastrointestinal pain—Betamethasone—hematologic cancer	2.7e-05	9.23e-05	CcSEcCtD
Timolol—Gastrointestinal pain—Dexamethasone—hematologic cancer	2.7e-05	9.23e-05	CcSEcCtD
Timolol—Dysgeusia—Epirubicin—hematologic cancer	2.69e-05	9.23e-05	CcSEcCtD
Timolol—Hypersensitivity—Triamcinolone—hematologic cancer	2.68e-05	9.17e-05	CcSEcCtD
Timolol—Nervousness—Epirubicin—hematologic cancer	2.67e-05	9.15e-05	CcSEcCtD
Timolol—Angiopathy—Doxorubicin—hematologic cancer	2.65e-05	9.08e-05	CcSEcCtD
Timolol—Dizziness—Etoposide—hematologic cancer	2.65e-05	9.07e-05	CcSEcCtD
Timolol—Immune system disorder—Doxorubicin—hematologic cancer	2.64e-05	9.04e-05	CcSEcCtD
Timolol—Vertigo—Methotrexate—hematologic cancer	2.64e-05	9.04e-05	CcSEcCtD
Timolol—Mediastinal disorder—Doxorubicin—hematologic cancer	2.64e-05	9.02e-05	CcSEcCtD
Timolol—Urticaria—Betamethasone—hematologic cancer	2.62e-05	8.97e-05	CcSEcCtD
Timolol—Urticaria—Dexamethasone—hematologic cancer	2.62e-05	8.97e-05	CcSEcCtD
Timolol—Musculoskeletal discomfort—Prednisone—hematologic cancer	2.62e-05	8.96e-05	CcSEcCtD
Timolol—Dizziness—Prednisolone—hematologic cancer	2.61e-05	8.95e-05	CcSEcCtD
Timolol—Arrhythmia—Doxorubicin—hematologic cancer	2.61e-05	8.95e-05	CcSEcCtD
Timolol—Asthenia—Triamcinolone—hematologic cancer	2.61e-05	8.93e-05	CcSEcCtD
Timolol—Abdominal pain—Dexamethasone—hematologic cancer	2.61e-05	8.92e-05	CcSEcCtD
Timolol—Body temperature increased—Dexamethasone—hematologic cancer	2.61e-05	8.92e-05	CcSEcCtD
Timolol—Abdominal pain—Betamethasone—hematologic cancer	2.61e-05	8.92e-05	CcSEcCtD
Timolol—Body temperature increased—Betamethasone—hematologic cancer	2.61e-05	8.92e-05	CcSEcCtD
Timolol—Nausea—Cisplatin—hematologic cancer	2.6e-05	8.89e-05	CcSEcCtD
Timolol—Insomnia—Prednisone—hematologic cancer	2.6e-05	8.89e-05	CcSEcCtD
Timolol—Vision blurred—Epirubicin—hematologic cancer	2.59e-05	8.88e-05	CcSEcCtD
Timolol—Alopecia—Doxorubicin—hematologic cancer	2.58e-05	8.85e-05	CcSEcCtD
Timolol—Paraesthesia—Prednisone—hematologic cancer	2.58e-05	8.83e-05	CcSEcCtD
Timolol—Pruritus—Triamcinolone—hematologic cancer	2.57e-05	8.8e-05	CcSEcCtD
Timolol—Cough—Methotrexate—hematologic cancer	2.57e-05	8.78e-05	CcSEcCtD
Timolol—Mental disorder—Doxorubicin—hematologic cancer	2.56e-05	8.77e-05	CcSEcCtD
Timolol—Vomiting—Etoposide—hematologic cancer	2.55e-05	8.72e-05	CcSEcCtD
Timolol—Malnutrition—Doxorubicin—hematologic cancer	2.55e-05	8.72e-05	CcSEcCtD
Timolol—Erythema—Doxorubicin—hematologic cancer	2.55e-05	8.72e-05	CcSEcCtD
Timolol—Dyspepsia—Prednisone—hematologic cancer	2.53e-05	8.65e-05	CcSEcCtD
Timolol—Rash—Etoposide—hematologic cancer	2.53e-05	8.65e-05	CcSEcCtD
Timolol—Dermatitis—Etoposide—hematologic cancer	2.52e-05	8.64e-05	CcSEcCtD
Timolol—Headache—Etoposide—hematologic cancer	2.51e-05	8.59e-05	CcSEcCtD
Timolol—Arthralgia—Methotrexate—hematologic cancer	2.5e-05	8.57e-05	CcSEcCtD
Timolol—Myalgia—Methotrexate—hematologic cancer	2.5e-05	8.57e-05	CcSEcCtD
Timolol—Chest pain—Methotrexate—hematologic cancer	2.5e-05	8.57e-05	CcSEcCtD
Timolol—Tension—Doxorubicin—hematologic cancer	2.5e-05	8.55e-05	CcSEcCtD
Timolol—Decreased appetite—Prednisone—hematologic cancer	2.5e-05	8.55e-05	CcSEcCtD
Timolol—Dysgeusia—Doxorubicin—hematologic cancer	2.49e-05	8.54e-05	CcSEcCtD
Timolol—Rash—Prednisolone—hematologic cancer	2.49e-05	8.53e-05	CcSEcCtD
Timolol—Dermatitis—Prednisolone—hematologic cancer	2.49e-05	8.52e-05	CcSEcCtD
Timolol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	2.49e-05	8.51e-05	CcSEcCtD
Timolol—Fatigue—Prednisone—hematologic cancer	2.48e-05	8.48e-05	CcSEcCtD
Timolol—Headache—Prednisolone—hematologic cancer	2.48e-05	8.48e-05	CcSEcCtD
Timolol—Discomfort—Methotrexate—hematologic cancer	2.47e-05	8.47e-05	CcSEcCtD
Timolol—Nervousness—Doxorubicin—hematologic cancer	2.47e-05	8.47e-05	CcSEcCtD
Timolol—Vertigo—Epirubicin—hematologic cancer	2.47e-05	8.46e-05	CcSEcCtD
Timolol—Syncope—Epirubicin—hematologic cancer	2.47e-05	8.45e-05	CcSEcCtD
Timolol—Palpitations—Epirubicin—hematologic cancer	2.43e-05	8.33e-05	CcSEcCtD
Timolol—Confusional state—Methotrexate—hematologic cancer	2.42e-05	8.28e-05	CcSEcCtD
Timolol—Loss of consciousness—Epirubicin—hematologic cancer	2.42e-05	8.28e-05	CcSEcCtD
Timolol—Dizziness—Triamcinolone—hematologic cancer	2.4e-05	8.23e-05	CcSEcCtD
Timolol—Cough—Epirubicin—hematologic cancer	2.4e-05	8.22e-05	CcSEcCtD
Timolol—Anaphylactic shock—Methotrexate—hematologic cancer	2.4e-05	8.22e-05	CcSEcCtD
Timolol—Vision blurred—Doxorubicin—hematologic cancer	2.4e-05	8.21e-05	CcSEcCtD
Timolol—Infection—Methotrexate—hematologic cancer	2.38e-05	8.16e-05	CcSEcCtD
Timolol—Nausea—Etoposide—hematologic cancer	2.38e-05	8.15e-05	CcSEcCtD
Timolol—Hypertension—Epirubicin—hematologic cancer	2.38e-05	8.13e-05	CcSEcCtD
Timolol—Feeling abnormal—Prednisone—hematologic cancer	2.37e-05	8.1e-05	CcSEcCtD
Timolol—Asthenia—Dexamethasone—hematologic cancer	2.37e-05	8.1e-05	CcSEcCtD
Timolol—Asthenia—Betamethasone—hematologic cancer	2.37e-05	8.1e-05	CcSEcCtD
Timolol—Nervous system disorder—Methotrexate—hematologic cancer	2.35e-05	8.06e-05	CcSEcCtD
Timolol—Gastrointestinal pain—Prednisone—hematologic cancer	2.35e-05	8.04e-05	CcSEcCtD
Timolol—Nausea—Prednisolone—hematologic cancer	2.35e-05	8.04e-05	CcSEcCtD
Timolol—Myalgia—Epirubicin—hematologic cancer	2.34e-05	8.02e-05	CcSEcCtD
Timolol—Arthralgia—Epirubicin—hematologic cancer	2.34e-05	8.02e-05	CcSEcCtD
Timolol—Chest pain—Epirubicin—hematologic cancer	2.34e-05	8.02e-05	CcSEcCtD
Timolol—Anxiety—Epirubicin—hematologic cancer	2.33e-05	7.99e-05	CcSEcCtD
Timolol—Pruritus—Dexamethasone—hematologic cancer	2.33e-05	7.99e-05	CcSEcCtD
Timolol—Pruritus—Betamethasone—hematologic cancer	2.33e-05	7.99e-05	CcSEcCtD
Timolol—Skin disorder—Methotrexate—hematologic cancer	2.33e-05	7.98e-05	CcSEcCtD
Timolol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	2.33e-05	7.97e-05	CcSEcCtD
Timolol—Hyperhidrosis—Methotrexate—hematologic cancer	2.32e-05	7.94e-05	CcSEcCtD
Timolol—Discomfort—Epirubicin—hematologic cancer	2.31e-05	7.92e-05	CcSEcCtD
Timolol—Vomiting—Triamcinolone—hematologic cancer	2.31e-05	7.91e-05	CcSEcCtD
Timolol—Rash—Triamcinolone—hematologic cancer	2.29e-05	7.84e-05	CcSEcCtD
Timolol—Dry mouth—Epirubicin—hematologic cancer	2.29e-05	7.84e-05	CcSEcCtD
Timolol—Dermatitis—Triamcinolone—hematologic cancer	2.29e-05	7.84e-05	CcSEcCtD
Timolol—Vertigo—Doxorubicin—hematologic cancer	2.29e-05	7.83e-05	CcSEcCtD
Timolol—Anorexia—Methotrexate—hematologic cancer	2.29e-05	7.83e-05	CcSEcCtD
Timolol—Syncope—Doxorubicin—hematologic cancer	2.28e-05	7.82e-05	CcSEcCtD
Timolol—Urticaria—Prednisone—hematologic cancer	2.28e-05	7.81e-05	CcSEcCtD
Timolol—Headache—Triamcinolone—hematologic cancer	2.28e-05	7.79e-05	CcSEcCtD
Timolol—Abdominal pain—Prednisone—hematologic cancer	2.27e-05	7.77e-05	CcSEcCtD
Timolol—Body temperature increased—Prednisone—hematologic cancer	2.27e-05	7.77e-05	CcSEcCtD
Timolol—Confusional state—Epirubicin—hematologic cancer	2.26e-05	7.75e-05	CcSEcCtD
Timolol—Diarrhoea—Betamethasone—hematologic cancer	2.26e-05	7.72e-05	CcSEcCtD
Timolol—Diarrhoea—Dexamethasone—hematologic cancer	2.26e-05	7.72e-05	CcSEcCtD
Timolol—Palpitations—Doxorubicin—hematologic cancer	2.25e-05	7.7e-05	CcSEcCtD
Timolol—Anaphylactic shock—Epirubicin—hematologic cancer	2.25e-05	7.69e-05	CcSEcCtD
Timolol—Oedema—Epirubicin—hematologic cancer	2.25e-05	7.69e-05	CcSEcCtD
Timolol—Hypotension—Methotrexate—hematologic cancer	2.24e-05	7.68e-05	CcSEcCtD
Timolol—Loss of consciousness—Doxorubicin—hematologic cancer	2.24e-05	7.66e-05	CcSEcCtD
Timolol—Infection—Epirubicin—hematologic cancer	2.23e-05	7.64e-05	CcSEcCtD
Timolol—Cough—Doxorubicin—hematologic cancer	2.22e-05	7.61e-05	CcSEcCtD
Timolol—Shock—Epirubicin—hematologic cancer	2.21e-05	7.56e-05	CcSEcCtD
Timolol—Nervous system disorder—Epirubicin—hematologic cancer	2.2e-05	7.54e-05	CcSEcCtD
Timolol—Hypertension—Doxorubicin—hematologic cancer	2.2e-05	7.53e-05	CcSEcCtD
Timolol—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.19e-05	7.49e-05	CcSEcCtD
Timolol—Skin disorder—Epirubicin—hematologic cancer	2.18e-05	7.47e-05	CcSEcCtD
Timolol—Dizziness—Dexamethasone—hematologic cancer	2.18e-05	7.46e-05	CcSEcCtD
Timolol—Dizziness—Betamethasone—hematologic cancer	2.18e-05	7.46e-05	CcSEcCtD
Timolol—Hyperhidrosis—Epirubicin—hematologic cancer	2.17e-05	7.43e-05	CcSEcCtD
Timolol—Insomnia—Methotrexate—hematologic cancer	2.17e-05	7.43e-05	CcSEcCtD
Timolol—Myalgia—Doxorubicin—hematologic cancer	2.17e-05	7.42e-05	CcSEcCtD
Timolol—Chest pain—Doxorubicin—hematologic cancer	2.17e-05	7.42e-05	CcSEcCtD
Timolol—Arthralgia—Doxorubicin—hematologic cancer	2.17e-05	7.42e-05	CcSEcCtD
Timolol—Anxiety—Doxorubicin—hematologic cancer	2.16e-05	7.4e-05	CcSEcCtD
Timolol—Nausea—Triamcinolone—hematologic cancer	2.16e-05	7.39e-05	CcSEcCtD
Timolol—Paraesthesia—Methotrexate—hematologic cancer	2.15e-05	7.38e-05	CcSEcCtD
Timolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	2.15e-05	7.37e-05	CcSEcCtD
Timolol—Discomfort—Doxorubicin—hematologic cancer	2.14e-05	7.33e-05	CcSEcCtD
Timolol—Anorexia—Epirubicin—hematologic cancer	2.14e-05	7.33e-05	CcSEcCtD
Timolol—Dyspnoea—Methotrexate—hematologic cancer	2.14e-05	7.32e-05	CcSEcCtD
Timolol—Somnolence—Methotrexate—hematologic cancer	2.13e-05	7.3e-05	CcSEcCtD
Timolol—Dry mouth—Doxorubicin—hematologic cancer	2.12e-05	7.26e-05	CcSEcCtD
Timolol—Hypersensitivity—Prednisone—hematologic cancer	2.12e-05	7.24e-05	CcSEcCtD
Timolol—Dyspepsia—Methotrexate—hematologic cancer	2.11e-05	7.23e-05	CcSEcCtD
Timolol—Hypotension—Epirubicin—hematologic cancer	2.1e-05	7.18e-05	CcSEcCtD
Timolol—Vomiting—Dexamethasone—hematologic cancer	2.1e-05	7.18e-05	CcSEcCtD
Timolol—Vomiting—Betamethasone—hematologic cancer	2.1e-05	7.18e-05	CcSEcCtD
Timolol—Confusional state—Doxorubicin—hematologic cancer	2.1e-05	7.17e-05	CcSEcCtD
Timolol—Decreased appetite—Methotrexate—hematologic cancer	2.09e-05	7.14e-05	CcSEcCtD
Timolol—Rash—Betamethasone—hematologic cancer	2.08e-05	7.12e-05	CcSEcCtD
Timolol—Rash—Dexamethasone—hematologic cancer	2.08e-05	7.12e-05	CcSEcCtD
Timolol—Oedema—Doxorubicin—hematologic cancer	2.08e-05	7.11e-05	CcSEcCtD
Timolol—Anaphylactic shock—Doxorubicin—hematologic cancer	2.08e-05	7.11e-05	CcSEcCtD
Timolol—Dermatitis—Betamethasone—hematologic cancer	2.08e-05	7.11e-05	CcSEcCtD
Timolol—Dermatitis—Dexamethasone—hematologic cancer	2.08e-05	7.11e-05	CcSEcCtD
Timolol—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.07e-05	7.09e-05	CcSEcCtD
Timolol—Fatigue—Methotrexate—hematologic cancer	2.07e-05	7.08e-05	CcSEcCtD
Timolol—Headache—Dexamethasone—hematologic cancer	2.07e-05	7.07e-05	CcSEcCtD
Timolol—Headache—Betamethasone—hematologic cancer	2.07e-05	7.07e-05	CcSEcCtD
Timolol—Infection—Doxorubicin—hematologic cancer	2.06e-05	7.07e-05	CcSEcCtD
Timolol—Asthenia—Prednisone—hematologic cancer	2.06e-05	7.05e-05	CcSEcCtD
Timolol—Pain—Methotrexate—hematologic cancer	2.05e-05	7.03e-05	CcSEcCtD
Timolol—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.05e-05	7e-05	CcSEcCtD
Timolol—Shock—Doxorubicin—hematologic cancer	2.04e-05	7e-05	CcSEcCtD
Timolol—Nervous system disorder—Doxorubicin—hematologic cancer	2.04e-05	6.98e-05	CcSEcCtD
Timolol—Pruritus—Prednisone—hematologic cancer	2.03e-05	6.96e-05	CcSEcCtD
Timolol—Insomnia—Epirubicin—hematologic cancer	2.03e-05	6.95e-05	CcSEcCtD
Timolol—Skin disorder—Doxorubicin—hematologic cancer	2.02e-05	6.91e-05	CcSEcCtD
Timolol—Paraesthesia—Epirubicin—hematologic cancer	2.02e-05	6.9e-05	CcSEcCtD
Timolol—Hyperhidrosis—Doxorubicin—hematologic cancer	2.01e-05	6.88e-05	CcSEcCtD
Timolol—Dyspnoea—Epirubicin—hematologic cancer	2e-05	6.85e-05	CcSEcCtD
Timolol—Somnolence—Epirubicin—hematologic cancer	2e-05	6.84e-05	CcSEcCtD
Timolol—Anorexia—Doxorubicin—hematologic cancer	1.98e-05	6.78e-05	CcSEcCtD
Timolol—Feeling abnormal—Methotrexate—hematologic cancer	1.98e-05	6.77e-05	CcSEcCtD
Timolol—Dyspepsia—Epirubicin—hematologic cancer	1.98e-05	6.77e-05	CcSEcCtD
Timolol—Diarrhoea—Prednisone—hematologic cancer	1.96e-05	6.73e-05	CcSEcCtD
Timolol—Gastrointestinal pain—Methotrexate—hematologic cancer	1.96e-05	6.72e-05	CcSEcCtD
Timolol—Nausea—Dexamethasone—hematologic cancer	1.96e-05	6.71e-05	CcSEcCtD
Timolol—Nausea—Betamethasone—hematologic cancer	1.96e-05	6.71e-05	CcSEcCtD
Timolol—Decreased appetite—Epirubicin—hematologic cancer	1.95e-05	6.68e-05	CcSEcCtD
Timolol—Hypotension—Doxorubicin—hematologic cancer	1.94e-05	6.65e-05	CcSEcCtD
Timolol—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.94e-05	6.64e-05	CcSEcCtD
Timolol—Fatigue—Epirubicin—hematologic cancer	1.94e-05	6.63e-05	CcSEcCtD
Timolol—Pain—Epirubicin—hematologic cancer	1.92e-05	6.57e-05	CcSEcCtD
Timolol—Urticaria—Methotrexate—hematologic cancer	1.91e-05	6.53e-05	CcSEcCtD
Timolol—Dizziness—Prednisone—hematologic cancer	1.9e-05	6.5e-05	CcSEcCtD
Timolol—Body temperature increased—Methotrexate—hematologic cancer	1.9e-05	6.49e-05	CcSEcCtD
Timolol—Abdominal pain—Methotrexate—hematologic cancer	1.9e-05	6.49e-05	CcSEcCtD
Timolol—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.89e-05	6.48e-05	CcSEcCtD
Timolol—Insomnia—Doxorubicin—hematologic cancer	1.88e-05	6.43e-05	CcSEcCtD
Timolol—Paraesthesia—Doxorubicin—hematologic cancer	1.87e-05	6.39e-05	CcSEcCtD
Timolol—Dyspnoea—Doxorubicin—hematologic cancer	1.85e-05	6.34e-05	CcSEcCtD
Timolol—Feeling abnormal—Epirubicin—hematologic cancer	1.85e-05	6.34e-05	CcSEcCtD
Timolol—Somnolence—Doxorubicin—hematologic cancer	1.85e-05	6.32e-05	CcSEcCtD
Timolol—Gastrointestinal pain—Epirubicin—hematologic cancer	1.84e-05	6.29e-05	CcSEcCtD
Timolol—Dyspepsia—Doxorubicin—hematologic cancer	1.83e-05	6.26e-05	CcSEcCtD
Timolol—Vomiting—Prednisone—hematologic cancer	1.83e-05	6.25e-05	CcSEcCtD
Timolol—Rash—Prednisone—hematologic cancer	1.81e-05	6.2e-05	CcSEcCtD
Timolol—Dermatitis—Prednisone—hematologic cancer	1.81e-05	6.19e-05	CcSEcCtD
Timolol—Decreased appetite—Doxorubicin—hematologic cancer	1.81e-05	6.18e-05	CcSEcCtD
Timolol—Headache—Prednisone—hematologic cancer	1.8e-05	6.16e-05	CcSEcCtD
Timolol—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.79e-05	6.14e-05	CcSEcCtD
Timolol—Fatigue—Doxorubicin—hematologic cancer	1.79e-05	6.13e-05	CcSEcCtD
Timolol—Urticaria—Epirubicin—hematologic cancer	1.78e-05	6.11e-05	CcSEcCtD
Timolol—Pain—Doxorubicin—hematologic cancer	1.78e-05	6.08e-05	CcSEcCtD
Timolol—Abdominal pain—Epirubicin—hematologic cancer	1.78e-05	6.08e-05	CcSEcCtD
Timolol—Body temperature increased—Epirubicin—hematologic cancer	1.78e-05	6.08e-05	CcSEcCtD
Timolol—Hypersensitivity—Methotrexate—hematologic cancer	1.77e-05	6.05e-05	CcSEcCtD
Timolol—Asthenia—Methotrexate—hematologic cancer	1.72e-05	5.89e-05	CcSEcCtD
Timolol—Feeling abnormal—Doxorubicin—hematologic cancer	1.71e-05	5.86e-05	CcSEcCtD
Timolol—Nausea—Prednisone—hematologic cancer	1.71e-05	5.84e-05	CcSEcCtD
Timolol—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.7e-05	5.82e-05	CcSEcCtD
Timolol—Pruritus—Methotrexate—hematologic cancer	1.7e-05	5.81e-05	CcSEcCtD
Timolol—Hypersensitivity—Epirubicin—hematologic cancer	1.65e-05	5.66e-05	CcSEcCtD
Timolol—Urticaria—Doxorubicin—hematologic cancer	1.65e-05	5.65e-05	CcSEcCtD
Timolol—Body temperature increased—Doxorubicin—hematologic cancer	1.64e-05	5.62e-05	CcSEcCtD
Timolol—Abdominal pain—Doxorubicin—hematologic cancer	1.64e-05	5.62e-05	CcSEcCtD
Timolol—Diarrhoea—Methotrexate—hematologic cancer	1.64e-05	5.62e-05	CcSEcCtD
Timolol—Asthenia—Epirubicin—hematologic cancer	1.61e-05	5.52e-05	CcSEcCtD
Timolol—Pruritus—Epirubicin—hematologic cancer	1.59e-05	5.44e-05	CcSEcCtD
Timolol—Dizziness—Methotrexate—hematologic cancer	1.59e-05	5.43e-05	CcSEcCtD
Timolol—Diarrhoea—Epirubicin—hematologic cancer	1.54e-05	5.26e-05	CcSEcCtD
Timolol—Hypersensitivity—Doxorubicin—hematologic cancer	1.53e-05	5.24e-05	CcSEcCtD
Timolol—Vomiting—Methotrexate—hematologic cancer	1.53e-05	5.22e-05	CcSEcCtD
Timolol—Rash—Methotrexate—hematologic cancer	1.51e-05	5.18e-05	CcSEcCtD
Timolol—Dermatitis—Methotrexate—hematologic cancer	1.51e-05	5.18e-05	CcSEcCtD
Timolol—Headache—Methotrexate—hematologic cancer	1.5e-05	5.15e-05	CcSEcCtD
Timolol—Asthenia—Doxorubicin—hematologic cancer	1.49e-05	5.1e-05	CcSEcCtD
Timolol—Dizziness—Epirubicin—hematologic cancer	1.49e-05	5.08e-05	CcSEcCtD
Timolol—Pruritus—Doxorubicin—hematologic cancer	1.47e-05	5.03e-05	CcSEcCtD
Timolol—Vomiting—Epirubicin—hematologic cancer	1.43e-05	4.89e-05	CcSEcCtD
Timolol—Nausea—Methotrexate—hematologic cancer	1.43e-05	4.88e-05	CcSEcCtD
Timolol—Diarrhoea—Doxorubicin—hematologic cancer	1.42e-05	4.87e-05	CcSEcCtD
Timolol—Rash—Epirubicin—hematologic cancer	1.42e-05	4.85e-05	CcSEcCtD
Timolol—Dermatitis—Epirubicin—hematologic cancer	1.41e-05	4.84e-05	CcSEcCtD
Timolol—Headache—Epirubicin—hematologic cancer	1.41e-05	4.82e-05	CcSEcCtD
Timolol—Dizziness—Doxorubicin—hematologic cancer	1.37e-05	4.7e-05	CcSEcCtD
Timolol—Nausea—Epirubicin—hematologic cancer	1.33e-05	4.57e-05	CcSEcCtD
Timolol—Vomiting—Doxorubicin—hematologic cancer	1.32e-05	4.52e-05	CcSEcCtD
Timolol—Rash—Doxorubicin—hematologic cancer	1.31e-05	4.49e-05	CcSEcCtD
Timolol—Dermatitis—Doxorubicin—hematologic cancer	1.31e-05	4.48e-05	CcSEcCtD
Timolol—Headache—Doxorubicin—hematologic cancer	1.3e-05	4.46e-05	CcSEcCtD
Timolol—Nausea—Doxorubicin—hematologic cancer	1.23e-05	4.23e-05	CcSEcCtD
Timolol—ADRB2—Signaling Pathways—CD86—hematologic cancer	8.1e-06	0.000132	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—ADCY7—hematologic cancer	8.07e-06	0.000131	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—NCOA3—hematologic cancer	8.07e-06	0.000131	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—JAK2—hematologic cancer	8.05e-06	0.000131	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—PIK3CA—hematologic cancer	8.03e-06	0.00013	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CSF2—hematologic cancer	8.03e-06	0.00013	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—FGF1—hematologic cancer	8.03e-06	0.00013	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—NUP214—hematologic cancer	8.01e-06	0.00013	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—MDM2—hematologic cancer	8e-06	0.00013	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	7.99e-06	0.00013	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—HES1—hematologic cancer	7.99e-06	0.00013	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—NCOR1—hematologic cancer	7.94e-06	0.000129	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—SDC1—hematologic cancer	7.93e-06	0.000129	CbGpPWpGaD
Timolol—ABCB1—Metabolism—GSTT1—hematologic cancer	7.92e-06	0.000129	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—FOXO1—hematologic cancer	7.91e-06	0.000129	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—IL2—hematologic cancer	7.91e-06	0.000128	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PDGFRB—hematologic cancer	7.9e-06	0.000128	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—FGF1—hematologic cancer	7.85e-06	0.000128	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CSF2—hematologic cancer	7.85e-06	0.000128	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—ABCG2—hematologic cancer	7.85e-06	0.000128	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—MTR—hematologic cancer	7.85e-06	0.000128	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—PIK3CB—hematologic cancer	7.82e-06	0.000127	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—MTOR—hematologic cancer	7.78e-06	0.000126	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—PIK3CB—hematologic cancer	7.78e-06	0.000126	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PDGFRA—hematologic cancer	7.77e-06	0.000126	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—JAK1—hematologic cancer	7.75e-06	0.000126	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PRKCG—hematologic cancer	7.75e-06	0.000126	CbGpPWpGaD
Timolol—ABCB1—Metabolism—SDC1—hematologic cancer	7.74e-06	0.000126	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—FOXO1—hematologic cancer	7.74e-06	0.000126	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—IL2—hematologic cancer	7.73e-06	0.000126	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PDGFRB—hematologic cancer	7.72e-06	0.000126	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—ENO2—hematologic cancer	7.7e-06	0.000125	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	7.69e-06	0.000125	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—PIK3CB—hematologic cancer	7.65e-06	0.000124	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PDGFRA—hematologic cancer	7.6e-06	0.000124	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	7.58e-06	0.000123	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—JAK1—hematologic cancer	7.58e-06	0.000123	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PRKCG—hematologic cancer	7.58e-06	0.000123	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	7.48e-06	0.000122	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—GSTT1—hematologic cancer	7.47e-06	0.000121	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—HRAS—hematologic cancer	7.43e-06	0.000121	CbGpPWpGaD
Timolol—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	7.42e-06	0.000121	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—CDKN1B—hematologic cancer	7.3e-06	0.000119	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—SDC1—hematologic cancer	7.3e-06	0.000119	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—IL2RA—hematologic cancer	7.23e-06	0.000118	CbGpPWpGaD
Timolol—ADRB3—GPCR downstream signaling—AKT1—hematologic cancer	7.22e-06	0.000117	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—IL2—hematologic cancer	7.18e-06	0.000117	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—CASP3—hematologic cancer	7.16e-06	0.000116	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	7.16e-06	0.000116	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—TERT—hematologic cancer	7.15e-06	0.000116	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—IL2—hematologic cancer	7.15e-06	0.000116	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—IL6—hematologic cancer	7.11e-06	0.000116	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—IL2RA—hematologic cancer	7.08e-06	0.000115	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—IL2—hematologic cancer	7.02e-06	0.000114	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—TERT—hematologic cancer	7e-06	0.000114	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PDGFB—hematologic cancer	6.98e-06	0.000113	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—CCND1—hematologic cancer	6.97e-06	0.000113	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—JUN—hematologic cancer	6.95e-06	0.000113	CbGpPWpGaD
Timolol—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	6.94e-06	0.000113	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PDGFB—hematologic cancer	6.83e-06	0.000111	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—TSC2—hematologic cancer	6.82e-06	0.000111	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—NQO1—hematologic cancer	6.75e-06	0.00011	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CD44—hematologic cancer	6.75e-06	0.00011	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—CDKN1A—hematologic cancer	6.74e-06	0.00011	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—PTEN—hematologic cancer	6.72e-06	0.000109	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—TSC2—hematologic cancer	6.68e-06	0.000108	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	6.6e-06	0.000107	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CD44—hematologic cancer	6.58e-06	0.000107	CbGpPWpGaD
Timolol—ABCB1—Metabolism—NQO1—hematologic cancer	6.58e-06	0.000107	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—MAPK8—hematologic cancer	6.58e-06	0.000107	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—FGFR3—hematologic cancer	6.56e-06	0.000107	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—AKT1—hematologic cancer	6.56e-06	0.000107	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—MAPK14—hematologic cancer	6.5e-06	0.000106	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—FGFR3—hematologic cancer	6.42e-06	0.000104	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—EP300—hematologic cancer	6.41e-06	0.000104	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CYCS—hematologic cancer	6.38e-06	0.000104	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—ESR1—hematologic cancer	6.38e-06	0.000104	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—MAPK14—hematologic cancer	6.36e-06	0.000103	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	6.34e-06	0.000103	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—FN1—hematologic cancer	6.3e-06	0.000102	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—ESR1—hematologic cancer	6.24e-06	0.000101	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—SRC—hematologic cancer	6.23e-06	0.000101	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CYCS—hematologic cancer	6.23e-06	0.000101	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—BAD—hematologic cancer	6.22e-06	0.000101	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—NFKBIA—hematologic cancer	6.22e-06	0.000101	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—NQO1—hematologic cancer	6.2e-06	0.000101	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CD44—hematologic cancer	6.2e-06	0.000101	CbGpPWpGaD
Timolol—ABCB1—Metabolism—HSP90AA1—hematologic cancer	6.19e-06	0.000101	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—NOTCH1—hematologic cancer	6.16e-06	0.0001	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—FN1—hematologic cancer	6.16e-06	0.0001	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—BAD—hematologic cancer	6.09e-06	9.89e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—NFKBIA—hematologic cancer	6.09e-06	9.89e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—VEGFA—hematologic cancer	6.07e-06	9.87e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CD80—hematologic cancer	6.04e-06	9.81e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—NOTCH1—hematologic cancer	6.03e-06	9.8e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PIK3CG—hematologic cancer	6.03e-06	9.79e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—KIT—hematologic cancer	6.03e-06	9.79e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—NRAS—hematologic cancer	6.03e-06	9.79e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—STAT3—hematologic cancer	6.01e-06	9.77e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—NRAS—hematologic cancer	6e-06	9.75e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PTPN11—hematologic cancer	5.92e-06	9.62e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CD80—hematologic cancer	5.91e-06	9.6e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—KIT—hematologic cancer	5.9e-06	9.58e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PIK3CG—hematologic cancer	5.9e-06	9.58e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—NRAS—hematologic cancer	5.9e-06	9.58e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CYCS—hematologic cancer	5.87e-06	9.54e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	5.83e-06	9.48e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PTPN11—hematologic cancer	5.79e-06	9.41e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—MAPK3—hematologic cancer	5.77e-06	9.38e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—MAPK3—hematologic cancer	5.74e-06	9.33e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CREB1—hematologic cancer	5.74e-06	9.32e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	5.71e-06	9.27e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—BRAF—hematologic cancer	5.66e-06	9.21e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—MAPK3—hematologic cancer	5.65e-06	9.17e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—GSTP1—hematologic cancer	5.63e-06	9.14e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CCL2—hematologic cancer	5.61e-06	9.12e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CREB1—hematologic cancer	5.61e-06	9.12e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—IL6R—hematologic cancer	5.6e-06	9.09e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CREBBP—hematologic cancer	5.59e-06	9.08e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—MYC—hematologic cancer	5.59e-06	9.08e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—TGFB1—hematologic cancer	5.57e-06	9.06e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—BRAF—hematologic cancer	5.54e-06	9.01e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—GSTP1—hematologic cancer	5.49e-06	8.92e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CCL2—hematologic cancer	5.49e-06	8.92e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—IL6R—hematologic cancer	5.47e-06	8.9e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CREBBP—hematologic cancer	5.47e-06	8.88e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	5.44e-06	8.85e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—MAP2K1—hematologic cancer	5.33e-06	8.67e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—ABCB1—hematologic cancer	5.33e-06	8.65e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PIK3CD—hematologic cancer	5.3e-06	8.61e-05	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—PIK3CA—hematologic cancer	5.25e-06	8.53e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—MAP2K1—hematologic cancer	5.22e-06	8.48e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—KRAS—hematologic cancer	5.19e-06	8.43e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PIK3CD—hematologic cancer	5.18e-06	8.42e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—GSTP1—hematologic cancer	5.17e-06	8.41e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—GSTM1—hematologic cancer	5.17e-06	8.4e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—NCOR1—hematologic cancer	5.17e-06	8.4e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—KRAS—hematologic cancer	5.16e-06	8.39e-05	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—PIK3CA—hematologic cancer	5.13e-06	8.34e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—KRAS—hematologic cancer	5.07e-06	8.25e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—FGF2—hematologic cancer	5.07e-06	8.24e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—NCOR1—hematologic cancer	5.05e-06	8.2e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—GSTM1—hematologic cancer	5.05e-06	8.2e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PIK3R1—hematologic cancer	5e-06	8.13e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—FGF2—hematologic cancer	4.96e-06	8.06e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—ABCB1—hematologic cancer	4.9e-06	7.96e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PIK3R1—hematologic cancer	4.89e-06	7.95e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—JAK2—hematologic cancer	4.86e-06	7.9e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—PIK3CA—hematologic cancer	4.77e-06	7.74e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—JAK2—hematologic cancer	4.76e-06	7.73e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—NCOR1—hematologic cancer	4.76e-06	7.73e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—GSTM1—hematologic cancer	4.76e-06	7.73e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—MDM2—hematologic cancer	4.75e-06	7.71e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—PIK3CA—hematologic cancer	4.74e-06	7.71e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—PIK3CA—hematologic cancer	4.66e-06	7.58e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—MDM2—hematologic cancer	4.64e-06	7.55e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—MTOR—hematologic cancer	4.62e-06	7.5e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PIK3CB—hematologic cancer	4.62e-06	7.5e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—TP53—hematologic cancer	4.59e-06	7.46e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—MTHFR—hematologic cancer	4.57e-06	7.42e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—MTOR—hematologic cancer	4.52e-06	7.34e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PIK3CB—hematologic cancer	4.52e-06	7.34e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—MTHFR—hematologic cancer	4.46e-06	7.25e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—HRAS—hematologic cancer	4.41e-06	7.16e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—HRAS—hematologic cancer	4.39e-06	7.13e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CDKN1B—hematologic cancer	4.33e-06	7.04e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—HRAS—hematologic cancer	4.31e-06	7.01e-05	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—AKT1—hematologic cancer	4.29e-06	6.97e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CASP3—hematologic cancer	4.25e-06	6.9e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—IL2—hematologic cancer	4.24e-06	6.89e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CDKN1B—hematologic cancer	4.24e-06	6.89e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—IL6—hematologic cancer	4.22e-06	6.86e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—MTHFR—hematologic cancer	4.2e-06	6.83e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—IL6—hematologic cancer	4.2e-06	6.82e-05	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—AKT1—hematologic cancer	4.19e-06	6.81e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CASP3—hematologic cancer	4.15e-06	6.75e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—IL2—hematologic cancer	4.15e-06	6.74e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CCND1—hematologic cancer	4.13e-06	6.72e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—IL6—hematologic cancer	4.13e-06	6.71e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—JUN—hematologic cancer	4.13e-06	6.7e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CCND1—hematologic cancer	4.04e-06	6.57e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—JUN—hematologic cancer	4.04e-06	6.56e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.03e-06	6.54e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CDKN1A—hematologic cancer	4e-06	6.5e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PTEN—hematologic cancer	3.99e-06	6.48e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CDKN1A—hematologic cancer	3.91e-06	6.36e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—MAPK8—hematologic cancer	3.9e-06	6.34e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PTEN—hematologic cancer	3.9e-06	6.34e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—AKT1—hematologic cancer	3.89e-06	6.33e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—AKT1—hematologic cancer	3.87e-06	6.3e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PIK3CG—hematologic cancer	3.84e-06	6.24e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—MAPK8—hematologic cancer	3.82e-06	6.21e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—AKT1—hematologic cancer	3.81e-06	6.19e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—EP300—hematologic cancer	3.81e-06	6.18e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PIK3CG—hematologic cancer	3.75e-06	6.09e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—EP300—hematologic cancer	3.72e-06	6.05e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—SRC—hematologic cancer	3.7e-06	6.01e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—SRC—hematologic cancer	3.62e-06	5.88e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—VEGFA—hematologic cancer	3.6e-06	5.86e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—STAT3—hematologic cancer	3.57e-06	5.8e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—NRAS—hematologic cancer	3.56e-06	5.79e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CREBBP—hematologic cancer	3.56e-06	5.78e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PIK3CG—hematologic cancer	3.53e-06	5.74e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—VEGFA—hematologic cancer	3.53e-06	5.73e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—STAT3—hematologic cancer	3.49e-06	5.67e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—NRAS—hematologic cancer	3.48e-06	5.66e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CREBBP—hematologic cancer	3.47e-06	5.65e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—MAPK3—hematologic cancer	3.41e-06	5.54e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PIK3CD—hematologic cancer	3.37e-06	5.48e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—MAPK3—hematologic cancer	3.34e-06	5.42e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—ALB—hematologic cancer	3.33e-06	5.41e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—MYC—hematologic cancer	3.32e-06	5.39e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—TGFB1—hematologic cancer	3.31e-06	5.38e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PIK3CD—hematologic cancer	3.29e-06	5.35e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CREBBP—hematologic cancer	3.27e-06	5.32e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—ALB—hematologic cancer	3.25e-06	5.28e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—MYC—hematologic cancer	3.24e-06	5.27e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—TGFB1—hematologic cancer	3.24e-06	5.26e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PIK3R1—hematologic cancer	3.19e-06	5.18e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PIK3R1—hematologic cancer	3.11e-06	5.05e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PIK3CD—hematologic cancer	3.1e-06	5.04e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—KRAS—hematologic cancer	3.06e-06	4.98e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—ALB—hematologic cancer	3.06e-06	4.98e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—KRAS—hematologic cancer	3e-06	4.87e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PIK3CB—hematologic cancer	2.94e-06	4.78e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PIK3R1—hematologic cancer	2.93e-06	4.76e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PIK3CB—hematologic cancer	2.87e-06	4.67e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PIK3CA—hematologic cancer	2.82e-06	4.57e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PIK3CA—hematologic cancer	2.75e-06	4.48e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—TP53—hematologic cancer	2.72e-06	4.43e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PIK3CB—hematologic cancer	2.71e-06	4.4e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—TP53—hematologic cancer	2.66e-06	4.33e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—HRAS—hematologic cancer	2.6e-06	4.23e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—HRAS—hematologic cancer	2.55e-06	4.14e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PTEN—hematologic cancer	2.54e-06	4.13e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—IL6—hematologic cancer	2.49e-06	4.05e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PTEN—hematologic cancer	2.48e-06	4.03e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—IL6—hematologic cancer	2.44e-06	3.96e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—EP300—hematologic cancer	2.42e-06	3.94e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—EP300—hematologic cancer	2.37e-06	3.84e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PTEN—hematologic cancer	2.34e-06	3.8e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—AKT1—hematologic cancer	2.3e-06	3.74e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—AKT1—hematologic cancer	2.25e-06	3.66e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—EP300—hematologic cancer	2.23e-06	3.62e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PIK3CA—hematologic cancer	1.79e-06	2.91e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PIK3CA—hematologic cancer	1.75e-06	2.84e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PIK3CA—hematologic cancer	1.65e-06	2.68e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—AKT1—hematologic cancer	1.46e-06	2.38e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—AKT1—hematologic cancer	1.43e-06	2.32e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—AKT1—hematologic cancer	1.35e-06	2.19e-05	CbGpPWpGaD
